8月11日 - ** 药物研发公司Gain Therapeutics（GANX.O ） 股价上涨5.4%，至1.86美元
** 据LSEG数据显示，GANX公布第二季度 每股亏损11美分 ，而分析师平均预期为每股亏损14美分
** 截至6月30日的三个月内，该公司研发费用较一年前的280万美元减少60万美元，降至210万美元
** 分析师平均预期研发费用为318万美元
** 截至6月30日，该公司现金及现金等价物为1,310万美元，而截至2025年12月31日为2,080万美元
** 计入本交易日走势后，该股年初至今累计下跌42.5%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.